Nicholas G Zaorsky

Summary

Publications

  1. doi request reprint High dose rate brachytherapy boost for prostate cancer: a systematic review
    Nicholas G Zaorsky
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Bodine Center for Cancer Treatment, 111 S 11th Street, Philadelphia, PA 19107, USA Electronic address
    Cancer Treat Rev 40:414-25. 2014
  2. pmc Systematic review of hypofractionated radiation therapy for prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Treat Rev 39:728-36. 2013
  3. doi request reprint Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Treat Rev 39:212-8. 2013
  4. doi request reprint The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Semin Oncol 40:322-36. 2013
  5. doi request reprint A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, PA, USA
    Future Oncol 10:457-74. 2014
  6. doi request reprint Evolution of advanced technologies in prostate cancer radiotherapy
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Nat Rev Urol 10:565-79. 2013
  7. pmc Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification me
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 118:5535-43. 2012
  8. doi request reprint Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Expert Rev Med Devices 10:751-63. 2013
  9. doi request reprint Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
    Nicholas G Zaorsky
    Department of Radiation Oncology Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA
    Expert Rev Anticancer Ther 14:39-50. 2014
  10. doi request reprint The effect of ethnicity and sexual preference on prostate-cancer-related quality of life
    Nir Kleinmann
    Department of Urology, Thomas Jefferson University Hospital, 833 Chestnut Street, Suite 703, Philadelphia, PA 19107, USA
    Nat Rev Urol 9:258-65. 2012

Collaborators

Detail Information

Publications16

  1. doi request reprint High dose rate brachytherapy boost for prostate cancer: a systematic review
    Nicholas G Zaorsky
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Bodine Center for Cancer Treatment, 111 S 11th Street, Philadelphia, PA 19107, USA Electronic address
    Cancer Treat Rev 40:414-25. 2014
    ..Comparative effectiveness research will help guide clinicians in selecting the most appropriate treatment option for individual patients based on risk-stratification, expected outcomes, toxicities, quality of life, and cost. ..
  2. pmc Systematic review of hypofractionated radiation therapy for prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Treat Rev 39:728-36. 2013
    ..High dose rate brachytherapy and stereotactic body radiation therapy (fraction size 3.5 Gy and greater) are alternative approaches to hypofractionation, but are beyond the scope of this report...
  3. doi request reprint Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Treat Rev 39:212-8. 2013
    ..Currently, SBRT regimens should only be used in the context of clinical trials...
  4. doi request reprint The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Semin Oncol 40:322-36. 2013
    ..In this article we review the current and future factors that clinicians should consider in the diagnosis and treatment of recurrent prostate cancer. ..
  5. doi request reprint A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, PA, USA
    Future Oncol 10:457-74. 2014
    ..Further studies are needed to establish the role of imaging techniques for detection of cancer recurrence and clinical decision-making. ..
  6. doi request reprint Evolution of advanced technologies in prostate cancer radiotherapy
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Nat Rev Urol 10:565-79. 2013
    ....
  7. pmc Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification me
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 118:5535-43. 2012
    ....
  8. doi request reprint Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Expert Rev Med Devices 10:751-63. 2013
    ..HDR-BT boost is now a relatively well-established treatment modality for certain intermediate-risk and high-risk prostate cancer patients, though limitations exist in drawing conclusions from the currently published studies. ..
  9. doi request reprint Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
    Nicholas G Zaorsky
    Department of Radiation Oncology Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA
    Expert Rev Anticancer Ther 14:39-50. 2014
    ..However, there are still certain limitations that preclude recommending HDR-BT monotherapy for prostate cancer outside the setting of a clinical trial. HDR-BT monotherapy should be considered experimental at present. ..
  10. doi request reprint The effect of ethnicity and sexual preference on prostate-cancer-related quality of life
    Nir Kleinmann
    Department of Urology, Thomas Jefferson University Hospital, 833 Chestnut Street, Suite 703, Philadelphia, PA 19107, USA
    Nat Rev Urol 9:258-65. 2012
    ..These parameters are often poorly documented and addressed by medical practitioners. Greater attention is needed to identify patients who are at increased risk of QOL reduction as a result of these factors...
  11. doi request reprint Multimodality therapy for patients with high-risk prostate cancer: current status and future directions
    Nicholas G Zaorsky
    Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Semin Oncol 40:308-21. 2013
    ..In this article, we review the transforming world of multimodality therapy in high-risk prostate cancer. ..
  12. pmc Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Int J Radiat Oncol Biol Phys 84:e13-7. 2012
    ..To present the largest retrospective series investigating the effect of aspirin and statins, which are hypothesized to have antineoplastic properties, on biochemical failure (nadir plus 2 ng/mL) after prostate radiation therapy (RT)...
  13. doi request reprint Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions
    Xinglei Shen
    Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    Future Oncol 8:37-54. 2012
    ....
  14. pmc ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
    Yunguang Sun
    Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Mol Cancer Ther 12:696-704. 2013
    ..Our findings indicate that PF02341066 acts as a radiation sensitizer in cells harboring the EML4-ALK fusion, providing a rationale for a clinical trial combining ALK inhibitor with radiation in the NSCLCs expressing ALK...
  15. doi request reprint Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
    Nicholas G Zaorsky
    Department of Radiation Oncology, Jefferson Medical College, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 83:e465-9. 2012
    ..Few medical students are given proper clinical training in oncology, much less radiation oncology. We attempted to assess the value of adding a radiation oncology clinical rotation to the medical school curriculum...
  16. doi request reprint Oncology training programs: are we doing comparative effectiveness research justice?
    Nicholas G Zaorsky
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    J Comp Eff Res 2:573-82. 2013
    ..Upper level trainees who have reached milestones related to CER will be competitive applicants for research funding. ..